Thailand
Narcotics Act No. 7 (2019) as medical basis; 2022 delisting from Category 5 opened adult-use briefly; 2025 controlled-herb notifications refocus on medical channels.
Last updated:
Active market models
- Medical only: Regulated medical prescription route; no adult-use retail or possession relief.
Developments
- — Narcotics Act No. 7 (medical basis)
Amendment allowing cannabis/hemp formulations for treatment or research under Thai FDA oversight.
Sources: Thai FDA
- — Delisting cannabis from Category 5 narcotics
MOPH Notification prescribing the updated list of Category 5 narcotics; removes cannabis, briefly enabling wider access.
Sources: Ministry of Public Health (Thailand)
- — Controlled-herb notifications refocus on medical channels
Ministry of Public Health notifications further restrict non-medical exploitation of cannabis.
Sources: Ministry of Public Health (Thailand)
Official sources
- Narcotics Act (No. 7), B.E. 2562 (2019) — Thai FDA — 2019-02-19
- MOPH Notification: List of Category 5 Narcotics, B.E. 2565 (2022) — Ministry of Public Health (Thailand) — 2022-06-09
All jurisdictions · Recent legal and policy developments · Source library